FGF21 was also found to be upregulated in numerous metabolic disorders, including diabetes17, obesity16, nonalcoholic fatty liver disease18, dyslipidemia, and coronary artery disease (CAD)19. The gene discussed is FGF21; the disease is metabolic disease.